Source:http://linkedlifedata.com/resource/umls/id/C2936588
NCI: A class of agents that target at platelet ADP receptor or purinergic receptor P2RY12 with antiplatelet activity.,MSH: Heterocyclic compounds that contain 4H,5H,6H,7H-thieno[2,3-c]pyridine as part of their structure.